Novo funded center behind new findings. (IMAGE)
Caption
Professor Kurt Gothelf is head of the Center for Multifunctional Biomolecular Drug Design (CEMBID) at Aarhus University, which is funded by the Novo Nordisk Foundation. They recently published in Angewandte Chemie Int. Ed. on the development of more stable nanostructures to provide more efficient in vivo diagnostics and therapeutics. (Photo: Lars Kruse, AU Photo)
Credit
Lars Kruse, AU Photo
Usage Restrictions
Image may be used only to illustrate the research described in the accompanying release. Credit required: Lars Kruse, AU Photo
License
Licensed content